In this study, we evaluated the effects of Nrf2 activator, Sulforaphane (SFN) and inhibitor, Trigonelline (TRN), on Nrf2-driven antioxidant pathways in human fetal membrane explants exposed to oxidative stress by infection or cigarette smoke components. This evidence concerns the gene NFE2L2 and infection.